Date: Aug 05, 2005 Source: bizjournals (
click here to go to the source)
Fisher Scientific International Inc. said it has acquired Cellomics Inc., a developer of technology for automated compound screening, for about $49 million in cash.
Fisher, a Hampton, N.H.-based laboratory equipment maker (NYSE:FSH) said the addition of Pittsburgh-based Cellomics will build on its "offering of drug-discovery solutions in the life-science marketplace, enabling researchers to accelerate the process of developing new medicines."
Cellomics, founded in 1996, had 2004 revenues of approximately $13 million.
Fisher, which makes lab equipment, supplies, as well as safety, healthcare, chemical and food safety products, has significant operations in the Pittsburgh area, including subsidiaries Fisher Research, Fisher Safety and Fisher Laboratory, as well as Fisher Clinical Services in Allentown, Pa.